Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Item
http://www.wikidata.org/entity/Q34511787
HER2/neu Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative Study.Screening tests: a review with examplesRelevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer.Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample.Comparison of HER2 testing among laboratories: Our experience with review cases retested at Moffitt Cancer Center in a two-year period.Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?The assessment of HER2 status in breast cancer: the past, the present, and the future.Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance.Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images.Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).Benefits of using the cell block method to determine the discordance of the HR/HER2 expression in patients with metastatic breast cancer.Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution.Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients
P2860

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Item
http://www.wikidata.org/entity/Q34511787
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Assessing the discordance rate ...... ed HER2-negative breast cancer
@ast
Assessing the discordance rate ...... ed HER2-negative breast cancer
@en
Assessing the discordance rate ...... ed HER2-negative breast cancer
@nl
type
label
Assessing the discordance rate ...... ed HER2-negative breast cancer
@ast
Assessing the discordance rate ...... ed HER2-negative breast cancer
@en
Assessing the discordance rate ...... ed HER2-negative breast cancer
@nl
prefLabel
Assessing the discordance rate ...... ed HER2-negative breast cancer
@ast
Assessing the discordance rate ...... ed HER2-negative breast cancer
@en
Assessing the discordance rate ...... ed HER2-negative breast cancer
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Assessing the discordance rate ...... ed HER2-negative breast cancer
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932